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We previously reported that accentuated expression of the endothelin-1 (ET-1)/endothelin B receptor (ETBR)
cascade is involved in the mechanism of hyperpigmentation in lentigo senilis (LS) lesions. The paracrine
mechanism underlying ultraviolet B (UVB)-induced hyperpigmentation in the skin may involve the stimulation of
the ET-1/ETBR cascade as well as the stem cell factor (SCF)/SCF receptor cascade. Therefore, we used RT-PCR and
immunohistochemistry to determine whether accentuated expression of the SCF/SCF receptor cascade is also
associated with the mechanism of hyperpigmentation in epidermal LS lesions. RT-PCR analysis demonstrated the
increased expression of mRNA transcripts for SCF (n¼ 7), but not for SCF receptor (n¼ 6) or growth-related
oncogene a (GROa) (n¼ 4) in LS lesions. Immunohistochemistry revealed markedly stronger staining for SCF but
not for GROa or basic ﬁbroblast growth factor (bFGF) in the lesional epidermis compared with the perilesional
epidermis. This increased staining for SCF was corroborated by western blotting analysis for SCF expression in the
lesional epidermis. These ﬁndings suggest that in addition to the stimulated expression of the ET-1/ETBR cascade,
the accentuated expression of SCF in lesional skin plays an important role in the mechanism involved in the
epidermal hyperpigmentation of LS.
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We have previously demonstrated that melanogenic para-
crine cytokine networks exist between various types of skin
cells in vitro, which serve to regulate melanocyte function.
Those networks include endothelin-1 (ET-1) (Yada et al,
1991; Imokawa et al, 1992, 1995), membrane-bound stem
cell factor (mSCF) (Hachiya et al, 2001), granulocyte
macrophage colony stimulating factor (GM-CSF) (Imokawa
et al, 1996a), and growth-related oncogene a (GROa
(Imokawa et al, 1998a) for melanocyte/keratinocyte inter-
actions, and soluble-type SCF (sSCF) and hepatocyte
growth factor (HGF) for melanocyte/fibroblast interactions
(Imokawa et al, 1998b). Consistent with these findings on
melanogenic paracrine cytokine networks in vitro, we have
shown that the upregulation of such networks is intrinsically
involved in the stimulation of melanocyte function in vivo in
several hyperpigmentary disorders, such as ultraviolet B
(UVB)-melanosis (Imokawa et al, 1995), lentigo senilis (LS)
(Kadono et al, 2001), cafe´ au lait macules (Okazaki et al,
2003), and dermatofibroma (Shishido et al, 2001). For
example, we reported that ET, which are secreted by
endothelial cells and that serve as potent vasoconstrictive
peptides (Yanagisawa et al, 1988), are associated with UVB-
induced hyperpigmentation via a mechanism by which
keratinocyte-derived ET stimulate human melanocyte pro-
liferation and melanization, leading to the epidermal
hyperpigmentation (Imokawa et al, 1992). Because there
are some similarities in the histopathology and localized
eruptions that predominantly affect sun-exposed areas in
UVB-induced hyperpigmentation and in LS, we previously
demonstrated the important role of the epidermal ET
cascade in the mechanism of hyperpigmentation in LS
lesions (Kadono et al, 2001), which is analogous to its role in
UVB-induced melanosis. In LS lesions of the epidermis,
keratinocyte-derived ET-1 mRNA is over-expressed by 3.6-
fold, which is accompanied by the increased expression
(6.8-fold) of its receptor, endothelin B receptor (ETBR)
mRNA, in neighboring melanocytes. This stimulates the
proliferation and melanogenesis of melanocytes, which
leads to the accentuated production of melanin in the
epidermis. Subsequently, we demonstrated that in addition
to the ET cascade, SCF and its receptor KIT are also
constitutively associated with UVB-induced hyperpigmen-
tation of the epidermis (Hachiya et al, 2001). This prompted
us to determine whether SCF and/or the SCF receptor are
also involved in the mechanism of hyperpigmentation of
epidermal LS lesions. In this study, we used RT-PCR
analysis, immunohistochemistry, and western blotting to
show that SCF and the SCF receptor are also over-
expressed in LS lesions.
Abbreviations: bFGF, basic fibroblast growth factor; ET, endothelin;
ETBR, endothelin B receptor; G3PDH, glyceraldehyde-3-phos-
phate dehydrogenase; GROa, growth-related oncogene a; HGF,
hepatocyte growth factor; LS, lentigo senilis; PBS, phosphate
buffered saline; RT-PCR, reverse transcription polymerase chain
reaction; SCF, stem cell factor; UVB, ultraviolet B
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Results
Clinical appearance and histochemistry of LS The
clinical appearance of LS is shown in Fig 1A. In H&E
sections, there is an acanthosis and a slight hyperplasia
with increased numbers of melanin granules in the basal
layer (Fig 1B). Further, toluidine blue staining reveals that
there is no difference in the number of metachromatically
stained mast cells in the upper dermis between the lesion
(10.8  6.0 per cm2) and the non-lesion (10.0  4.8 per cm2)
of LS (Fig 1C,D).
Expression of SCF, c-KIT, and GROa mRNA transcripts
in LS lesions To examine whether the increased melano-
genesis in LS lesions is associated with accentuated
expression of the SCF ligand/receptor cascade, we
examined the expression of SCF and c-KIT mRNAs using
RT-PCR. Analysis of SCF mRNA demonstrated a signifi-
cantly increased expression (average 3.9-fold, n¼7,
po0.01) in LS lesions compared with perilesional normal
skin (Fig 2). SCF produced by keratinocytes triggers the
activation of the membrane tyrosine kinase-dependent
signaling pathway in human melanocytes through the SCF
receptor (Imokawa et al, 2000). Therefore, we determined
whether expression of c-KIT was also accentuated in
melanocytes in the LS lesions. RT-PCR of c-KIT mRNA
revealed no significant difference in the expression (average
1.16-fold, n¼ 6, NS) of c-KIT mRNA transcripts between
non-lesional and LS lesional skin, although there was a wide
variation in expression in some cases (Fig 3). As GROa is
known as a post-inflammatory mitogen for human melano-
cytes (Imokawa et al, 1998a), we determined whether GROa
transcripts are also upregulated in the LS lesions. By RT-
PCR analysis, no significant difference (average 1.13-fold,
n¼4, NS) in the expression of GROa transcripts was
detected between non-lesional and LS lesional skin (Fig 4).
To examine whether there were variations in the patterns of
expression of the mRNA transcripts tested, we compared
the expression of SCF, c-KIT, ET-1, tyrosinase, and ETBR
transcripts in the epidermis of the same donor with LS. RT-
PCR analysis of those mRNAs revealed a reproducible
expression pattern for each transcript that was similar to the
above results (Fig 5). The ET-1, tyrosinase, and ETBR
transcripts were upregulated concomitant with the upregu-
lation of SCF transcripts in the epidermis of LS relative to
the perilesional normal epidermis.
Immunohistochemistry To confirm the upregulated pro-
duction of SCF in LS lesions, we examined whether the
production of this cytokine in LS lesions actually reflects the
changes observed in its transcript levels. Staining with
antibodies against SCF revealed a distinct positive immu-
noreactivity throughout the epidermis in LS lesions,
whereas there was only a weakly positive staining in the
perilesional normal control (n¼ 10, Table I, Fig 6). In
contrast, and consistent with the expression of GROa
transcripts, there was no difference in immunostaining with
GROa antibodies between the LS lesional and non-lesional
epidermis (n¼10, Table I). Further, there was no difference
in the immunostaining with an antibody to bFGF, another
keratinocyte-derived mitogen for human melanocytes (Ha-
laban et al, 1988) (n¼10, Table I). To determine whether the
expression of SCF is upregulated concomitantly with the
expression of ET-1, we performed immunohistochemistry in
the skin of the same individuals used for SCF immunostain-
ing. Immunohistochemistry using an antibody for ET-1
revealed a distinct positive immunoreactivity throughout
the basal layer and along the lower epidermis in LS,
whereas there was only a weakly positive staining in the
perilesional normal control (n¼ 10, Table I, Fig 7). Thus,
consistent with the concomitant increases in the expression
of those transcripts in the skin of the same individuals, the
increased expression of SCF protein occurs concomitantly
with the increased expression of tyrosinase and ET-1
proteins.
Figure 1
Clinical appearance (A) and histology (B, C,
and D) of lentigo senilis (LS). (A) Clinical
appearance of LS (Patient 1) in the upper arm
of a Japanese female aged 70 y; there is an
increased basal pigmentation and a slight
acanthosis with prolonged rete ridges in the
lesional epidermis in LS. (B) Hematoxylin and
eosin (H&E) staining,  50 (Patient 1). (C)
Toluidine blue staining in the lesion,  50
(Patient 27). (D) Toluidine blue staining in the
non-lesion,  50 (Patient 27).
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Western blotting analysis To determine whether SCF
protein is substantially upregulated in the LS lesional
epidermis, we measured SCF protein levels by western
blotting. There is an increase in membrane-bound SCF
protein (31 kDa) in the LS lesional epidermis compared with
the non-lesional epidermis (Fig 8A). In contrast, there is no
detectable band of soluble SCF protein (18 kDa, corre-
sponding to recombinant SCF) in the LS lesional or in the
Figure 2
RT-PCR analysis of stem cell factor
(SCF) mRNA in the epidermis of lentigo
senilis (LS) lesions and in perilesional
skin. (A) Fluorogram, (B) densitometric
analysis. NL: non-lesional epidermis; L:
lesional epidermis of LS. Fluorograms are
shown at 34 or 40 cycles of PCR for SCF
and at 22 or 35 cycles for glyceraldehyde-
3-phosphate dehydrogenase (G3PDH).
po0.01, po0.05.
Figure 3
RT-PCR analysis of c-kit mRNA in the
epidermis of lentigo senilis (LS) lesions
and in perilesional skin. (A) Fluorogram,
(B) densitometric analysis. NL: Non-le-
sional epidermis; L: lesional epidermis of
LS. Fluorograms are shown at 35 or 40
cycles of PCR for c-KIT and at 25 or 35
cycles for glyceraldehyde-3-phosphate
dehydrogenase (G3PDH). NS: not signifi-
cant.
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non-lesional epidermis. Western blotting using six different
LS skins revealed a significant increase (average 1.6-fold,
n¼6, po0.05) in the membrane-bound SCF protein (31
kDa) in the LS lesional epidermis compared with the non-
lesional epidermis (Fig 8B,C). In contrast, soluble SCF (18
kDa) was not detected in any LS lesional or non-lesional
epidermis. This western blotting analysis is consistent with
the results showing increased immunostaining for SCF in
the LS lesional epidermis.
Discussion
LS is characterized by pigmented spots resulting from slight
hyperkeratosis and acanthosis of the skin with increased
melanin deposits localized in the basal and suprabasal
layers of the epidermis, which are attributable to the
stimulated proliferation and melanogenesis of melanocytes.
In LS lesional epidermis, there is an increased number of
tyrosinase-positive melanocytes accompanied by an in-
creased expression of tyrosinase mRNA in the skin (Kadono
et al, 2001). Because the clinical and histochemical features
of LS are similar to UVB-induced hyperpigmentation in
terms of a generally high localization to sun-exposed areas
as well as the appearance of basal pigmentation and
acanthosis, we hypothesized that the paracrine cytokine
mechanism underlying UVB-induced pigmentation would
be highly similar to the mechanism of hyperpigmentation in
LS. Thus, in paracrine interactions between keratinocytes
and melanocytes following UVB-exposure, we have pre-
viously reported that an accentuated secretion of ET-1 by
UVB-exposed human keratinocytes in culture is primarily
responsible for the increased proliferation and melanogen-
esis of cultured human melanocytes (Imokawa et al, 1992).
Taken together with the stimulated expression of ET-1 in
UVB-exposed human epidermis (Imokawa et al, 1995), the
potent melanogenic effect of ET-1 on cultured melanocytes
via the ETBR (Imokawa et al, 2000), and the fact that ETBR
antagonists can inhibit UVB-induced hyperpigmentation
in vivo (Imokawa et al, 1997), we have established the
physiological relevance of over-expression of ET-1 in UVB-
induced hyperpigmentation. Based upon this evidence, we
used immunohistochemistry and RT-PCR analysis to clarify
the role of the ET cascade, including the production of ET
and its processing by endothelin-converting enzyme (ECE),
and expression of ETBR, in the hyperpigmentary mechan-
ism(s) involved in LS. We found that the expression of ET-1
and its receptor, ETBR, are simultaneously augmented in the
lesional epidermis of LS (Kadono et al, 2001). The sum of
these findings suggested that the augmented production
Figure 4
RT-PCR analysis of growth-related on-
cogene a (GROa) mRNA in lentigo
senilis (LS) lesions and in perilesional
skin. (A) Fluorogram, (B) densitometric
analysis. NL: Non-lesional epidermis; L:
lesional epidermis of LS. Fluorograms are
shown at 31 cycles of PCR for GROa and
at 22 cycles for glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH). NS: not
significant.
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and subsequent secretion of ET-1 by keratinocytes as well
as the increased expression of ETBR by melanocytes play
essential roles in the epidermal hyperpigmentation of LS
(Kadono et al, 2001).
As another mechanism involved in UVB-induced hyper-
pigmentation, we recently demonstrated that in addition to
the stimulation of the ET-1/ETBR cascade, exposure to UVB
radiation stimulates the production of SCF in cultured
human keratinocytes and increases the expression of c-KIT
(the SCF receptor) in cultured human melanocytes (Hachiya
et al, 2001). Consistent with these effects of UVB irradiation
in vitro, UVB irradiation of human epidermis increases the
expression of SCF mRNA transcripts (assessed by RT-PCR)
and SCF protein (assessed by western blotting), which
is accompanied by increased immunostaining of SCF
throughout the UVB-exposed epidermis (Hachiya et al,
2001). More importantly, the induction of pigmentation can
be completely abolished by injection of an antibody to the
SCF receptor in exposed areas after UVB radiation, which
is accompanied by no increase in the number of dopa-positive
melanocytes within 6 d post-irradiation. Collectively, these
findings strongly suggest an intrinsic involvement of
accentuated expression of the SCF/SCF receptor cascade
in UVB-induced hyperpigmentation. Thus, based upon the
similarities in mechanisms involved in melanogenic para-
crine networks between UVB-induced hyperpigmentation
and LS, as well as the pivotal role of SCF in melanocyte
activation, we assessed the potential involvement of the
SCF/SCF receptor cascade in the accentuated melanogen-
esis seen in LS lesions.
This study demonstrates that SCF expression is mark-
edly accentuated in the epidermis of LS lesions. Thus, LS
lesional epidermis expresses increased levels of SCF
mRNA transcripts concomitantly with increased levels of
SCF protein compared with non-lesional controls. In
contrast, other melanogenic paracrine cytokines (GROa or
bFGF) have similar levels of mRNA expression and
immunostaining in LS lesional and in non-lesional skin.
SCF is markedly increased in immunohistochemical staining
throughout the LS lesional epidermis, and this is corrobo-
rated by western blotting using an antibody to SCF. In
contrast, the mRNA level of the SCF receptor, c-KIT,
remains unchanged in the lesional epidermis of LS
compared with the non-lesional epidermis. In epidermal
keratinocytes, SCF is expressed as a membrane-bound
form, and not in a secretory or soluble cytokine form such
as ET-1 (Hachiya et al, 2001). Even under stimulated
conditions such as following UVB exposure, only the
membrane-bound form of SCF is accentuated without
the appearance of soluble SCF (Hachiya et al, 2001). In
contrast, dermal fibroblasts can secrete soluble SCF,
probably as a result of the action of proteolytic enzymes
capable of cleaving membrane-bound SCF to release
soluble SCF (Imokawa et al, 1998b). In epidermal hyper-
pigmentation of dermatofibroma (Shishido et al, 2001) or
cafe-a´u-lait macules (Okazaki et al, 2003), soluble SCF
secreted by dermal fibroblasts plays an important role in
activating epidermal melanocytes via a dispersion pathway
through the basement membrane from the dermis toward
the epidermis. In cases where soluble SCF is involved in the
activation of epidermal melanocytes, dermal mast cells also
accumulate or increase in the upper dermis, and SCF is also
known as mast cell growth factor. Consistent with this,
Longley et al (1993) demonstrated that abnormalities in the
proteolytic processing of SCF tend to produce soluble SCF
in the epidermis, which leads to the phenotype of
mastocytosis. Further, Kunisada et al, (1998) reported that
the over-expression of soluble SCF in murine epidermis
induces the accumulation of mast cells in the dermis in
addition to increasing the number of melanocytes in the
epidermis. In our study, because the number of mast cells is
not increased in the lesional dermis of LS and because
soluble SCF is not detected in the lesional epidermis by
western blotting, it is likely that the accentuated production
of membrane-bound SCF plays an essential role in the
increased proliferation and melanogenesis of melanocytes,
leading to the epidermal hyperpigmentation in LS. This is
consistent with Kunisada’s report (Kunisada et al, 1998) using
mouse skin, in which the expression of membrane-bound
Figure 5
RT-PCR analysis of various transcripts used in the epidermis of the
same donor with lentigo senilis (LS) and perilesional skin. NL: Non-
lesional epidermis; L: lesional epidermis of LS. Fluorograms are shown
at 45, 40, 40, 40, 40, and 35 cycles of PCR for ET-1, endothelin B
receptor (ETBR), tyrosinase, stem cell factor (SCF), c-KIT, and
glyceraldehyde-3-phosphate dehydrogenase (G3PDH), respectively.
The numbers above the bands represent the densitometric intensities
of those bands.
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SCF alone resulted in epidermal melanocytosis and melanin
production, but did not by itself cause mastocytosis.
Although it has not been completely elucidated how
membrane-bound SCF produced by surrounding keratino-
cytes interacts with KIT tyrosine kinase on neighboring
melanocytes to transduce signaling, our previous evidence
that a monoclonal antibody to the SCF receptor can abolish
UVB-stimulated proliferation and melanogenesis of epider-
mal melanocytes strongly suggests that membrane-bound
SCF produced by keratinocytes can directly interact with
the SCF receptor on melanocytes to activate melanocyte
function. Therefore, in the interaction between membrane-
bound SCF and the SCF receptor, it seems unlikely that
following binding of SCF, the SCF receptor is internalized
into the cytoplasm to be digested, leading to downregula-
tion of the SCF receptor by increased epidermal SCF
Table I. Summary of LS patients examined and experiments performed
Patient
number Age Sex Lesion site
Macule
size (mm) RT-PCR
Western
blotting
Immunohistochemistry
SCF GROa bFGF ET-1
L/NL L/NL L/NL L/NL
1 72 M Upper arm 10 SCF/GROa
2 68 M Upper arm 10 SCF/GROa
3 56 F Neck 8 SCF/GROa
4 76 M Upper leg 7 SCF/GROa
5 85 F Upper arm 8 SCF/ETBR/c-KIT/ET-1/Tyrosinase
6 35 M Back 7 SCF/ETBR/c-KIT/ET-1/Tyrosinase
7 65 M Lower leg 10 SCF/ c-KIT
8 82 M Face 8 c-KIT
9 63 F Upper leg 8 SCF
10 72 F Face 7 SCF
11 48 M Upper leg 8 SCF
12 75 M Lower arm 10 SCF
13 80 M Upper arm 8 SCF
14 66 F Back 7 SCF
15 66 M Neck 7 c-KIT
16 68 F Abdomen 10 c-KIT
17 71 F Upper arm 10 c-KIT
18 74 F Upper arm 8 þ þ / þ /þ þ /  þ þ /
19 73 F Upper arm 7 þ /  /þ þ /þ þ þ / 
20 67 M Abdomen 10 þ þ /   /  þ /þ þ /
21 73 F Upper leg 8 c-KIT
22 74 F Back 7 c-KIT
23 70 M Upper arm 10 þ þ / þ /þ  /þ þ / 
24 52 M Abdomen 10 þ /  /þ  /   /
25 62 M Upper arm 10 þ þ /  þ /þ þ /þ þ /
26 61 M Upper leg 10 þ /  þ /þ  / þ þ þ / 
27 78 F Upper arm 10 þ þ /  /  /  þ /
28 58 F Upper leg 10 þ þ /  þ /þ þ /þ  /
29 81 M Neck 10 þ þ /   /  þ /  þ /
M, male; F, female; L, lesion; NL, non-lesion; , no staining;  , weak staining;þ , moderate staining; þ þ , marked staining.
LS, lentigo senilis; SCF, stem cell factor; GROa, growth-related oncogene a; bFGF, basic fibroblast growth factor; ET-1, endothelin-1; ETBR, endothelin
B receptor.
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production. Consistently, our RT-PCR analysis of c-KIT
mRNA revealed that the level of c-KIT transcript remains
unchanged in the lesional epidermis of LS compared with
the non-lesional epidermis. Therefore, it would be of
importance to determine whether the increased production
of membrane-bound SCF in keratinocytes in LS lesional
epidermis is involved via SCF/SCF receptor binding-
induced signaling in the activation of melanocytes attribu-
table to their increased proliferation and melanogenesis.
But characterizing receptor activation assessed by its
stimulated phosphorylation or by injection of a blocking
antibody to the SCF receptor will present great challenges.
Based on the previous in vitro evidence associating the
SCF/SCF receptor cascade with the activation of melano-
cytes (Imokawa et al, 1996b) and the in vitro and in vivo
evidence for the association of the SCF/SCF receptor with
UVB-induced-hyperpigmentation (Hachiya et al, 2001), our
results strongly suggest that the stimulated melanogenesis
in LS lesional epidermis is involved in the accentuated
expression of membrane-bound SCF in LS lesional kerati-
nocytes.
In conclusion, we propose that the stimulation of two
epidermal cascades, consisting of the ET-1/ETBR and the
SCF/SCF receptor, play important roles in the mechanism of
hyperpigmentation in LS. The concomitant accentuated
expression of both linkages was also confirmed for ET-1,
ETB,R and tyrosinase by RT-PCR analysis and for ET-1 by
immunohistochemistry in the same donor tested for SCF.
The preference for enhanced expression of ET-1 and SCF
and the melanogenic stimulation of melanocytes in LS
lesional epidermis is corroborated by the synergistic effects
of SCF and ET-1 in prompting melanogenesis and mitogen-
esis in cultured human melanocytes via transactivation of
SCF-stimulated KIT protein as a result of protein-kinase C
activated by ET-1 (Imokawa et al, 2000). These marked
synergistic effects are restricted to the cross-talk type of
interactions only between ET-1 and SCF among the
cytokines we have tested. Thus, it is likely that although
there are multiple and complex mechanisms involved in the
accentuated pigmentation of LS lesions, the coordinated
and synergistic roles of SCF and ET-1 in the intracellular
signaling mechanisms leading to melanogenesis (Imokawa
et al, 2000) may support the rationale for such ligand
specificity in the melanogenic stimulation of LS lesions.
Collectively, our findings suggest that in addition to the
stimulated ET cascade, the accentuated expression of
membrane-bound SCF also contributes to the epidermal
hyperpigmentation seen in LS lesions.
Figure 6
Immunohistochemistry with an antibody to stem cell factor (SCF)
in the epidermis of a lentigo senilis (LS) lesion: Patient 20 (A)
Lesional skin (  100), (B) non-lesional skin (  100).
Figure7
Immunostaining with an endothelin-1 (ET-1) antibody in the
epidermis of the same donor with lentigo senilis (LS) as used for
stem cell factor (SCF) immunostaining (in Fig 6). Patient 20: (A)
Lesional skin; (B) non-lesional skin (  100).
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Materials and Methods
Chemicals The streptavidin–biotin immunoperoxidase staining
system was obtained from Shandon–Lipshaw (Pittsburgh, Penn-
sylvania).
Antibodies Polyclonal antibodies against recombinant human
SCF, GROa ET-1, bFGF, b-actin, and tyrosinase were purchased
from Immuno Biological Laboratories (Gunma, Japan).
Samples Skin biopsy specimens (approximately 10 mm  10 mm)
were obtained from 29 Japanese patients with LS (males¼ 16,
females¼ 13), whose clinical appearance and epidermal histology
Figure 8
Western blotting of stem cell factor
(SCF) protein in the epidermis of
lentigo senilis (LS) lesions. (A) A
representative fluorogram in western
blotting, (B) fluorogram of six LS skins,
(C) densitometric analysis of (B). Ex-
tracts of separated epidermis from LS
lesions (5 mg protein per lane) were
subjected to 16.5% (A) or 15% (B)
acrylamide gel electrophoresis, followed
by electroblotting and then immunos-
taining with antibodies to SCF as noted.
The protein staining was concomitant-
ly performed with Coomassie Brilliant
Blue according to standard procedures.
po0.01, po0.05; NHKC: UVB (40
mJ per cm2) exposed normal human
keratinocytes. Cell lysate was taken 24
h after UVB radiation; recSCF: recombi-
nant SCF.
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are shown in Fig 1. In this study, perilesional skin is considered to
be non-lesional normal skin. These patients ranged in age from 35
to 85 y (average 68 y). The sites of skin excisions were on the back,
the dorsal surface of the arm, the leg, and the abdomen, which are
generally sun-protected skin areas, and there were no symptoms
of sun exposure when the biopsies were taken. The main portion of
each specimen was processed for routine histopathologic exam-
ination. Additional specimens were embedded in Tissue–Tek OCT
compound (Sakura Finetechnical Co., Ltd, Tokyo, Japan), snap-
frozen in liquid nitrogen for immunohistochemistry, homogenized
with acid guanidine phenol chloroform for RT-PCR analysis, and/or
frozen as intact skin at 801C until epidermal separation for
western blotting. All samples were stored at 801C until use.
Informed written consent was obtained from each patient prior to
skin sampling. A summary of LS patients examined is listed in
Table I.
Immunohistochemistry Cryostat sections (4 mm thick) were air-
dried, fixed in cold acetone, and after washing in 0.01 M
phosphate-buffered saline (PBS), were incubated in 3% H2O2 for
5 min at room temperature. After further washing in 0.01 M PBS,
the sections were incubated with protein blocking agent (Block
Ace, UK-B25: Dainippon Pharmacy, Osaka, Japan) for 20 min at
room temperature. The sections were then washed again in 0.01 M
PBS and incubated overnight at 41C in 0.01 M PBS, pH 7.2, with
antibodies to SCF, GROa, bFGF, ET-1, or tyrosinase. After further
washing in 0.01 M PBS, the sections were incubated for 30 min at
room temperature with biotinylated rabbit IgG antibody, washed
again in 0.01 M PBS, and incubated for 30 min at room
temperature with standard Omnitags streptavidin–peroxidase.
Reactions were then developed with aminoethylcarbazole (AEC).
Sections were incubated for 10–15 min at room temperature with
Omnitags plus/HRP kit (consisting of two drops of sodium acetate
buffer, two drops of AEC chromogen concentrate, and two drops
of 3% H2O2 in distilled water), washed in PBS, and counter-stained
with hematoxylin and eosin (H&E). The intensity of staining
throughout the epidermis is expressed as—(no staining),
 (weak staining), þ (moderate staining) or þ þ (marked staining)
(Table I).
Detection of SCF, c-KIT, ET-1, ETBR, tyrosinase, and GROa
mRNA transcripts from LS lesional and from perilesional
normal skin Biopsy specimens were obtained from LS and from
perilesional skin as detailed above. The epidermal sheet of each
specimen was separated by heating for 3 min at 601C. The residue
of the separated tissue was examined after periodic acid-Schiff
staining to confirm that the separation took place within the
epidermis, leaving no dermal components on the epidermal sheet.
Total cellular RNA was extracted from the separated epidermis,
using acid guanidine phenol chloroform with only a single
precipitation. The RNA was quantified by measuring the optical
density at 260 nm. About 1 mg total RNA was obtained from each
tissue sample. The total RNA was colored brown, probably as a
result of contamination with melanin. Therefore, total RNA was
further purified to poly AþRNA using an oligo(dT) resin (Oligotex-
dT30, Takara Co., Shiga, Japan), which greatly reduced the color.
Oligo(dT)-primed cDNA was synthesized from the poly Aþ RNA
and the cDNA was subjected to PCR using a RNA PCR kit (Gene
Amp RNA PCR kit, Perkin Elmer Cetus, Norwalk, Connectitut). The
PCR cycle conditions were as follows: denaturation for 1 min at
951C, annealing for 1 min at 601C, and extension for 2 min at 721C.
Reaction products were resolved on agarose gels to quantitate the
expression of the transcripts. The quantification was conducted at
cycles before the amplification reached saturation. The intensities
of the PCR bands were determined with a digital densitometer and
are expressed relative to glyceraldehyde-3-phosphate dehydro-
genase (G3PDH). The sequences of the 30 and 50 primer pairs
used in this study are shown in Table II. As negative controls, we
conducted PCR without RT and confirmed that there was no
amplification of the transcripts.
Western blotting To measure SCF expression in the epidermis of
LS lesions, the separated epidermal sheets were homogenized
with a glass homogenizer in 100 mL extraction buffer (0.1 M Tris-
HCl, pH 7.2/1.0% Nonidet P–40/0.1% SDS/protease inhibitor
cocktail), and then sonicated for 5 min with a Bioruptor (Olympus,
Tokyo, Japan). After centrifugation at 8000  g for 10 min at 41C,
the supernatants were collected and western blotting analysis was
performed as described elsewhere (Mizutani et al, 1994). Briefly,
5 mg of each sample and 0.075 mg recombinant human SCF
(Sigma, St Louis, Missouri) were electrophoresed in 15% SDS gels
and were then electrophoretically transferred to polyvinylidene
difluoride membranes. In some cases, the samples were electro-
phoretically separated on 16.5% acrylamide gel for low molecular
weight (Ready-Gel Peptide, Bio-Rad Laboratories, California) in
Tris/Tricine/SDS run buffer. After blocking with 3% skim milk, the
membranes were incubated with polyclonal rabbit antisera against
human SCF (SCF89; IBL, Gunma, Japan) at 5 mg per mL for 1 h
as the primary antibody. The antibody binding was visualized with
peroxidase-labeled anti-rabbit IgG (Amersham Biotech, New
Jersey) and ECL chemiluminescence reagent (Amersham Biotech).
To confirm cell extract quality, protein concentration, and transfer
efficiency, protein staining was concomitantly performed with
Coomassie Brilliant Blue according to standard procedures.
Loading controls were also performed by western blotting using
an antibody to b-actin (Santa Cruz Biotechnology Inc., California).
Protein concentrations of the extracts were determined by the
micro-BCA assay (Pierce, Illinois). To quantitate the expression of
proteins, the intensities of protein bands were measured by
densitometry and are expressed as relative intensities.
Table II. Nucleotide sequences for 50 and 30 primers
SCF
50 primer 50-GATGTTTTGCCAAGTCATTGTTGG-30
30 primer 50-ACTGACTCTGGAATCTTTCTCAGG-30
GROa
50 primer 50-GGATCCAAGCAAATGGCCAATGAG-30
30 primer 50-TGTTCTAAGCCAGAAACACTG-30
c-kit
50 primer TTCTTACCAGGTGGCAAAGGGCATGGCTTTCC
30 primer GTCATACATTTCAGCAGGTGCGTGTTCAGGGC
Endothelin-1
50 primer 50-TTCCCACAAAGGCAACAGACCG-30
30 primer 50-GACAGGCCCCGAAGTCTGTCA-30
Tyrosinase
50 primer 50-TATGAATGGAACAATGTCCCAGGT-30
30 primer 50-ATGACCAGATCCGACTCGCTTG-30
ETB receptor
50primer 50-CGAGCTGTTGCTTCTTGGAGTAG-30
30 primer 50-AACGGAAGTTGTCATATCCGTGAT-30
G3PDH
50 primer 50-GAAGGTGAAGGTCGGAGTCAACG-30
30 primer 50-AGTCCTTCCACGATACCAAAGTTG-30
SCF, stem cell factor; GROa, growth-related oncogene a; ETB,
endothelin B; G3PDH, glyceraldehyde-3-phosphate dehydrogenase.
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Statistics The level of significance of differences was calculated
by the Student’ t test.
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